| Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age ≥ 70 y | 0.864 (0.335–2.229) | 0.763 |  |  |
Female sex | 1.019 (0.523–1.984) | 0.857 |  |  |
Stage IV disease | 3.469 (1.217–9.890) | 0.020* | 2.887 (0.998–8.347) | 0.050 |
Central or lobar location | 1.009 (0.519–1.961) | 0.979 |  |  |
Central, lobar, or segmental location | 1.808 (0.246–13.316) | 0.561 |  |  |
Multiple | 1.170 (0.574–2.384) | 0.106 |  |  |
Bilateral | 1.131 (0.572–2.236) | 0.723 |  |  |
Combined with DVT | 1.182 (0.611–2.287) | 0.620 |  |  |
ECOG PS > 1 | 2.901 (1.310–6.426) | 0.009* | 1.779 (0.766–4.134) | 0.181 |
Low BMI | 0.048 (0.000–6908.772) | 0.617 |  |  |
Overweight | 0.402 (0.205–0.786) | 0.008* | 0.490 (0.245–0.983) | 0.045* |
Obesity | 0.734 (0.284–1.897) | 0.523 |  |  |
Anticoagulation therapy | 1.322 (0.633–2.763) | 0.457 |  |  |
Thrombolytic therapy | 4.845 (0.611–38.452) | 0.135 |  |  |
Filter implantation | 0.493 (0.118–2.057) | 0.332 |  |  |
Bleeding event | 0.585 (0.178–1.916) | 0.375 |  |  |